SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:4fdb859d-1490-4249-b78b-a460cb4e73d3"
 

Search: onr:"swepub:oai:lup.lub.lu.se:4fdb859d-1490-4249-b78b-a460cb4e73d3" > Computerized cognit...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Wesnes, K. (author)

Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease

  • Article/chapterEnglish2010

Publisher, publication year, extent ...

  • 2009-12-28
  • Hindawi Limited,2010

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:4fdb859d-1490-4249-b78b-a460cb4e73d3
  • https://lup.lub.lu.se/record/1697905URI
  • https://doi.org/10.1111/j.1600-0404.2009.01309.xDOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-123428URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:121235881URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • Objectives - Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) has become a standard clinical trials outcome for cognition, but has been recognized as deficient in areas including coverage of cognitive domains, sensitivity and standardization. Computerized test batteries may address some of these issues. The cognitive drug research computerized assessment (CDR) system is validated in Alzheimer's disease (AD). This study was designed to further evaluate validity in relation to ADAS-Cog, mini mental state examination (MMSE) and cerebrospinal fluid (CSF) biomarkers and psychometric properties, in a population of Alzheimer's patients on stable anticholinesterase treatment. Materials and methods - Patients completed cognition assessments, CSF and blood sampling at baseline and 6 months later. Data for 65 patients were evaluated. Results - The CDR system demonstrated good psychometric properties in this population. Measures of psychomotor speed showed possible sensitivity to decline over 6 months. Conclusions - There are a number of methodological problems with current cognition assessment methodology for clinical trials. Computerized measures and in particular millisecond reaction time measures, may address many of these issues.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Edgar, C. (author)
  • Andreasen, N.Karolinska Institutet (author)
  • Annas, P.Karolinska Institutet (author)
  • Basun, HansUppsala universitet,Geriatrik(Swepub:uu)habas169 (author)
  • Lannfelt, LarsUppsala universitet,Geriatrik(Swepub:uu)lalan021 (author)
  • Zetterberg, H. (author)
  • Blennow, K. (author)
  • Minthon, LennartLund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups(Swepub:lu)psyk-lmi (author)
  • Karolinska InstitutetGeriatrik (creator_code:org_t)

Related titles

  • In:Acta Neurologica Scandinavica: Hindawi Limited122:4, s. 270-2771600-04040001-6314

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view